发明公开
EP1212041A1 FORMULATIONS FOR PARENTERAL USE OF ESTRAMUSTINE PHOSPHATE AND SULFOALKYL ETHER CYCLODEXTRINS
审中-公开
适用非肠道药物制剂含磷酸雌莫司汀和SULPHOALKYLCYCLODEXTRINE
- 专利标题： FORMULATIONS FOR PARENTERAL USE OF ESTRAMUSTINE PHOSPHATE AND SULFOALKYL ETHER CYCLODEXTRINS
- 专利标题（中）： 适用非肠道药物制剂含磷酸雌莫司汀和SULPHOALKYLCYCLODEXTRINE
-
申请号： EP00958398.0申请日： 2000-08-03
-
公开(公告)号： EP1212041A1公开(公告)日： 2002-06-12
- 发明人: MUGGETTI, Lorena , COLOMBO, Paolo , MARTINI, Alessandro , BUZZI, Giovanni
- 申请人： Pharmacia Italia S.p.A.
- 申请人地址： Via Robert Koch 1.2 20152 Milano IT
- 专利权人： Pharmacia Italia S.p.A.
- 当前专利权人： Pharmacia Italia S.p.A.
- 当前专利权人地址： Via Robert Koch 1.2 20152 Milano IT
- 优先权： GB9921958 19990916
- 国际公布： WO0119339 20010322
- 主分类号： A61K9/08
- IPC分类号： A61K9/08 ; A61K47/40 ; A61K31/565 ; A61P35/00
摘要：
A pharmaceutical formulation which comprises a parenterally acceptable carrier or diluent, estramustine phosphate and a sulfoalkyl ether cyclodextrin. The formulation can be administered according to a combined chemotherapy regimen in association with one or more chemotherapeutic agents. The formulation also enables estramustine phosphate to be administered with no side effects at the site of injection.
信息查询
